"I'm very proud of the team we have assembled, with each Engagement Partner possessing complementary skill sets, a dedication to grow the business, and attention to detail. Every one of our professionals has already established themselves as a valuable industry asset, with a track record of success."
Scott has enjoyed a long and distinguished career in the discovery, development and commercialization of products to diagnose and treat patients around the world. He founded the Bruder Consulting and Venture Group in 2015 after 25 years in the industrial sector, serving in the C-Suites of Stryker Corporation as the Chief Medical and Scientific Officer, and at BD, as the Chief Science and Technology Officer, where he also led Corporate Business Development. Previously, while at Johnson & Johnson, he and his team built a portfolio of tissue repair products for the DePuy franchise before establishing a new business unit known as J&J Regenerative Therapeutics, LLC. Earlier in his career, he was the first scientist hired by Osiris Therapeutics, a mesenchymal stem cell company based on the work of his PhD mentor, Prof. Arnold Caplan. In addition to his tenure through industry, Dr. Bruder has maintained an active academic presence, serving as an Adjunct Professor of Biomedical Engineering at Case Western Reserve University since 2011, after 13 years as adjunct faculty in the Department of Orthopaedic Surgery. Currently, he also serves on the Board of Directors of both publicly held and private equity backed medical device companies.
Dr. Bruder's inventions, technologies and teams have launched dozens of products, earning billions of dollars for his employers and patent licensors. He has published more than 125 original articles, book chapters and abstracts, and lectured extensively around the world. He is the recipient of numerous honors, and is both the youngest and only industry scientist to receive the Kappa Delta Award from the American Academy of Orthopaedic Surgeons, the Marshall R. Urist Award for Excellence in Tissue Regeneration Research from the Orthopedic Research Society, and the Pierre Galletti Award from the American Institute for Medical and Biological Engineering, all of which represent the highest scientific honors bestowed by these organizations. He also served three years as the Industry Member on the FDA Advisory Committee on Cellular, Tissue and Gene Therapies. Dr. Bruder received his Sc.B. from Brown University, and both his MD and PhD from CWRU School of Medicine before post-graduate clinical training at the Albert Einstein Medical Center and the University of Pennsylvania. Scott resides in Northern New Jersey with his beloved wife and dog, and has two daughters in college and graduate school.
Jim is a seasoned medical device/biotechnology executive with strategy and tactical experience spanning both the device and regenerative medicine platforms, including drug/device combination products, cell-based implants, allograft and biomaterials. He has extensive experience with early-stage start-ups, emerging companies, Class III medical devices and PMAs. His expertise as a scientist and analytical business professional provides clients with an extremely valuable viewpoint that bridges multiple functions. Jim is a graduate of the University of Michigan (BS, MS) and Santa Clara University (MBA).
Jerry has enjoyed a long, successful career focused on business development in the biotech areas with more recent experience in the medical device sector. He has focused on technology out-licensing, product in-licensing, acquisitions, and manufacturing / commercialization agreements. His ability to rapidly translate complex scientific concepts into practical commercial opportunities sought by target partners has made him a valuable asset to many companies. Jerry is a graduate of Brown University (BA) and the Kellogg School of Management at Northwestern University (MBA).
Rebecca is a well-rounded executive with significant general management experience as well as specific experience identifying business opportunities, developing strategies, managing business relationships, and driving results. She has held leadership roles in start-up companies, high growth companies, and publicly traded companies in the Orthopaedics and Regenerative Medicine space. Her ability to think strategically and tactically, to solve problems, and to assess the landscape from both a business and a technical perspective, has enabled her to assist clients with a wide range of projects. Rebecca is a graduate of the University of Florida (BS, MS, MBA).
Gloria is a seasoned Executive Assistant with over 20 years of experience in the MedTech and Healthcare industries. Gloria’s excellent time management, communication and organization skills allow her to handle a broad scope of administrative responsibilities simultaneously. Gloria is familiar with complex calendar management, global travel coordination, videoconference and event planning, presentation creation, financial book-keeping and many other customer-facing, administrative support and office management functions. Gloria is a graduate of Berkeley College in lives in Northern New Jersey near BCVG headquarters.
Lisa joined BCVG as our Artistic Director in 2017. She has a wide array of experiences creating original art and curating a modest collection of private pieces. Lisa provides support as needed for internal design projects, client partner meetings and travel logistics. Lisa is a graduate of the Ohio State University (BA) and Cleveland State University (M.Ed.) and lives with Scott in Northern New Jersey, where she also maintains a precious metal art studio.
Kristen is a highly motivated regulatory affairs and quality professional with more than 15 years of experience in Class I instrument, and Class II/III implantable device submissions to the FDA and European regulatory bodies. She is familiar with FDA Guidance Documents, and navigates them with precision and creative insight. Her experience also includes management of post-market compliance, safety & recall decisions, establishment registrations, and Quality System requirements such as Design Control, CAPA and HCP contracting. Kristen is a graduate of the University of North Carolina at Wilmington (BS).
NIcola draws on a foundation of experience serving 21 years in regulatory affairs leadership roles with Allergan and Johnson & Johnson medical device companies. She has been instrumental in obtaining PMA product approvals and 510(k) clearances for a diverse number of products, including devices used in plastic and reconstructive surgery, dermatology, gastroenterology, cardiology, and ophthalmology. Nicola brings significant expertise in defining regulatory pathways, determining regulatory strategies, and executing successful regulatory submissions to gain product approvals.
Sumitra is an accomplished regulatory professional with over 23 years of drug, device and combination product development experience. She has worked in both big pharma and small biotech firms, most recently in the cellular therapy and drug delivery space. With a proven track record of developing and delivering regulatory strategies and approvals, Sumitra has deep knowledge of FDA regulations and guidance for both drugs and devices, including regenerative medicine products, and she keeps current on the regulatory landscape. Sumitra earned her RAC and is a graduate of the University of Kansas (BA, BS).
Suzanne is a passionate and insightful engineer with scientific expertise and business development experience in the field of orthobiologics and regenerative medicine. In academia, Suzanne led the early stages of commercialization for several orthobiologics technologies and currently plays an active role in multiple societies. In industry, she successfully drove market development strategy and new business opportunities. Her understanding of the market landscape, science, and technical aspects of commercialization provide her a unique ability to work effectively cross-functionally and solve a diverse set of problems. Suzanne is a Biomedical Engineering graduate of Clemson University (PhD) and The Ohio State University (BS).
Doug is a skilled technical executive serving the regenerative medicine, biotechnology, and medical device industries, with expertise in global product development, preclinical and clinical research, manufacturing and operations, and strategic business development. His broad experience developing and commercializing technologies includes cell therapies, bone and tissue graft products, and real-time cell and protein processing systems for use in the orthopedics, cardiovascular, plastic & reconstructive surgery, and wound markets. Doug excels in balancing big-picture corporate and customer needs with engineering, biological, and operational requirements. Doug is a biomedical engineering graduate of Johns Hopkins (BS) and the University of Washington (PhD),
Nilla played an essential role during the company’s genesis in 2015, providing inspiration and companionship. From her humble beginning as our first associate, she was promoted to Chief Canine Officer in 2016. She attentively monitors all client video- and tele-conferences, as well as internal planning sessions with staff. Nilla is known for her delightful demeanor, comforting style and willingness to work long hours for dehydrated bovine liver treats. Nilla is a magna cum laude graduate of the Loyal Companion Puppy School in Sudbury, Massachusetts.